The Department of Health – Abu Dhabi (DoH) has signed a significant Memorandum of Understanding (MoU) with various global and local leaders in the healthcare sector. This agreement aims to create a collaborative framework that will advance the future of healthcare through precision medicine and innovative therapies. Key partners in this initiative include PureHealth, Khalifa...
The United Arab Emirates has signed a significant agreement with the pharmaceutical giant GSK to collaborate on genomic science and precision medicine. This partnership aims to enhance health initiatives in the region, reflecting Abu Dhabi’s commitment to advancing healthcare through innovative scientific research. GSK’s Chief Executive Officer highlighted the project as “bold,” emphasizing its potential...
His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has approved the launch of the Health, Endurance, Longevity, and Medicine (HELM) cluster. This initiative aims to enhance medical innovation, advance pharmaceutical manufacturing, and promote developments in biotechnology within the region....
The UAE’s organ donation program, particularly the Hayat initiative, is making significant strides in transforming lives through medical advancements. According to Khaleej Times, Nada Al Ammari, a recipient of a pancreas and kidney transplant, shared her powerful story during the Abu Dhabi Global Health Week. She highlighted that the medical innovations discussed at the event...
The Department of Health – Abu Dhabi (DoH), the Abu Dhabi Investment Office (ADIO), and GSK, a global leader in biopharmaceuticals, have joined forces to establish a Multi-Omics Research Institute in Abu Dhabi. This partnership was formalized with a Memorandum of Understanding (MoU) signed during the Abu Dhabi Global Health Week (ADGHW). The initiative aims...
Burjeel Holdings, a prominent healthcare provider in the UAE, has partnered with the US-based non-profit Caring Cross to locally produce CAR-T (Chimeric Antigen Receptor T-cell) therapies. This collaboration will lead to a significant reduction in treatment costs for aggressive cancers, such as leukemia and lymphoma, making therapies available at up to 90% less than current...
Mediclinic Middle East, a prominent private healthcare provider in the UAE, has unveiled plans for a significant investment exceeding Dh120 million at its flagship facility, Mediclinic Airport Road Hospital in Abu Dhabi. This investment will be directed toward enhancing and expanding the hospital’s healthcare infrastructure, thereby improving access to high-quality medical services for patients and...
Abu Dhabi is planning to construct an advanced cancer treatment center, which will be the first of its kind in the Middle East. This initiative is part of a multibillion-dollar effort to diversify the emirate’s economy and enhance its healthcare sector. The facility will be developed through a partnership between M42’s Cleveland Clinic Abu Dhabi...
Burjeel Holdings has officially launched the Genetics and Rare Disease Center, aiming to enhance healthcare access for patients with rare and genetic diseases in the MENA region. The center is strategically located within Burjeel Medical City (BMC), a leading quaternary care hospital. It provides comprehensive, integrated care and state-of-the-art services for individuals affected by these...
Siemens Healthineers has successfully concluded its Innovation Capacity Building Program in Saudi Arabia, which took place from February 5 to February 20, 2025. This program aimed to enhance local innovation expertise and foster collaborations with universities, hospitals, startups, and key stakeholders, including Monshaat, the Small and Medium Enterprises General Authority. A total of 40 participants...